Stock Analysis on Net

Elevance Health Inc. (NYSE:ELV)

$24.99

Income Statement

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Paying users area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Elevance Health Inc., consolidated income statement

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Premiums
Product revenue
Service fees
Operating revenue
Benefit expense
Cost of products sold
Cost of operating revenue
Gross profit
Operating expense
Amortization of other intangible assets
Operating income
Fixed maturity securities
Equity securities
Cash equivalents
Other invested assets
Investment income
Investment expense
Net investment income
Net gains (losses) on financial instruments
Interest expenses
Loss on extinguishment of debt
Income before income tax expense
Income tax expense
Net income
Net (gain) loss attributable to noncontrolling interests
Shareholders’ net income

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Income statement item Description The company
Operating revenue Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Elevance Health Inc. operating revenue increased from 2021 to 2022 and from 2022 to 2023.
Operating income The net result for the period of deducting operating expenses from operating revenues. Elevance Health Inc. operating income increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.
Income before income tax expense Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Elevance Health Inc. income before income tax expense decreased from 2021 to 2022 and from 2022 to 2023.
Shareholders’ net income The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Elevance Health Inc. shareholders’ net income decreased from 2021 to 2022 and from 2022 to 2023.